Fundraising Fox

Peptron

1 known investors

Find your way into Peptron

Peptron develops long-acting (sustained-release) drug formulations using its proprietary drug delivery system (DDS) technology, including its SmartDepot platform, and provides peptide synthesis services under ISO9001 quality management. The South Korean biopharmaceutical company focuses on patient-friendly therapeutics.

BiotechMedical Devices

Investors · 1

Aju IB Invesment CorporationSeoul

In the news

Peptron wins permit for $60 mil. FDA-standard plant to scale long-acting peptide drugs < Bio < Article - KBRkoreabiomed.com · Dec 2025Peptron plunges as Eli Lilly's new deal raises uncertainty - CHOSUNBIZbiz.chosun.com · Jun 2025Peptron, Inc. announced that it has received KRW 2 billion in funding from UNO & COMPANY Ltd. -April 24, 2016 | MarketScreeneruk.marketscreener.com · Apr 2016Peptron, Inc. (087010) Stock Analysis & Key Metrics | KoalaGainskoalagains.com

Frequently asked questions

What does Peptron do?
Peptron develops long-acting (sustained-release) drug formulations using its proprietary drug delivery system (DDS) technology, including its SmartDepot platform, and provides peptide synthesis services under ISO9001 quality management. The South Korean biopharmaceutical company focuses on patient-friendly therapeutics.
Who are Peptron's investors?
Peptron's investors include Aju IB Invesment Corporation.